Efficacy of low-dose imatinib mesylate for cutaneous involvement in systemic sclerosis: a preliminary report of three cases View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2012-02

AUTHORS

Zenshiro Tamaki, Yoshihide Asano, Masaru Hatano, Atsushi Yao, Tomohiko Kawashima, Manabu Tomita, Koichiro Kinugawa, Ryozo Nagai, Shinichi Sato

ABSTRACT

In this pilot study, the effect of low-dose imatinib mesylate (100 mg/day) on cutaneous involvement in patients with systemic sclerosis (SSc) was analyzed. Three patients with SSc were treated with 100 mg/day of imatinib mesylate for 6 months because of pulmonary arterial hypertension refractory to conventional treatments, including beraprost, bosentan, sildenafil, and epoprostenol. Changes in cutaneous involvement were evaluated at 1, 3, and 6 months. During the treatment, the total skin score gradually improved in all of the patients. Contracture of phalanges was attenuated in two patients, one of whom also experienced the partial restoration of large-joint mobility. Nailfold bleeding, initially seen in two patients, was gradually attenuated and had completely disappeared at 6 months. In all patients, Raynaud's phenomenon was attenuated at around 3 months and had completely disappeared at 6 months. Although transient renal dysfunction was observed in one patient, none of the patients experienced common adverse effects of imatinib, such as edema, nausea, rash, and musculoskeletal pain. These clinical data indicate the tolerability and efficacy of low-dose imatinib in SSc, especially against cutaneous vascular involvement, including Raynaud's phenomenon and nailfold bleeding. More... »

PAGES

94-99

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10165-011-0472-1

DOI

http://dx.doi.org/10.1007/s10165-011-0472-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1047602676

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21633912


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Benzamides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Contracture", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemorrhage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Imatinib Mesylate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nail Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nails", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Piperazines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Kinase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrimidines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Range of Motion, Articular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Raynaud Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Scleroderma, Systemic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Skin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Tokyo", 
          "id": "https://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tamaki", 
        "givenName": "Zenshiro", 
        "id": "sg:person.01340530726.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340530726.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Tokyo", 
          "id": "https://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Asano", 
        "givenName": "Yoshihide", 
        "id": "sg:person.01272415526.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272415526.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Tokyo", 
          "id": "https://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hatano", 
        "givenName": "Masaru", 
        "id": "sg:person.0725464671.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725464671.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Tokyo", 
          "id": "https://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yao", 
        "givenName": "Atsushi", 
        "id": "sg:person.01260257610.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260257610.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Tokyo", 
          "id": "https://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kawashima", 
        "givenName": "Tomohiko", 
        "id": "sg:person.01066532711.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066532711.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Tokyo", 
          "id": "https://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tomita", 
        "givenName": "Manabu", 
        "id": "sg:person.0704171111.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704171111.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Tokyo", 
          "id": "https://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kinugawa", 
        "givenName": "Koichiro", 
        "id": "sg:person.016511126157.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016511126157.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Tokyo", 
          "id": "https://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nagai", 
        "givenName": "Ryozo", 
        "id": "sg:person.0772176333.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772176333.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Tokyo", 
          "id": "https://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sato", 
        "givenName": "Shinichi", 
        "id": "sg:person.012237517602.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012237517602.74"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.2353/ajpath.2010.090593", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001970034"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1529-0131(199905)42:5<930::aid-anr11>3.0.co;2-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006073505"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/ar2067", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006941478", 
          "https://doi.org/10.1186/ar2067"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/mcb.01278-08", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007691359"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0001452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011299071"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00392-009-0752-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015411619", 
          "https://doi.org/10.1007/s00392-009-0752-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/mcb.01320-08", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015563261"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.22314", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017502522"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s100670050039", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024420316", 
          "https://doi.org/10.1007/s100670050039"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1536/ihj.51.272", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024533354"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2009-02-204156", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026415910"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.20214", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026529165"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/onc.2008.479", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033606906", 
          "https://doi.org/10.1038/onc.2008.479"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.m703907200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033962722"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.21948", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034706037"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.25.0779", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035509430"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1164/rccm.200702-178oc", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037047078"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/ard.2010.143974", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040415220"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/rheumatology/ken104", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045972598"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/14656566.4.6.963", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046161832"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9440(10)63685-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047996226"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1346-8138.2009.00758.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051092432"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1346-8138.2009.00758.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051092432"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4414/smw.2010.13050", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072527631"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-02", 
    "datePublishedReg": "2012-02-01", 
    "description": "In this pilot study, the effect of low-dose imatinib mesylate (100 mg/day) on cutaneous involvement in patients with systemic sclerosis (SSc) was analyzed. Three patients with SSc were treated with 100 mg/day of imatinib mesylate for 6 months because of pulmonary arterial hypertension refractory to conventional treatments, including beraprost, bosentan, sildenafil, and epoprostenol. Changes in cutaneous involvement were evaluated at 1, 3, and 6 months. During the treatment, the total skin score gradually improved in all of the patients. Contracture of phalanges was attenuated in two patients, one of whom also experienced the partial restoration of large-joint mobility. Nailfold bleeding, initially seen in two patients, was gradually attenuated and had completely disappeared at 6 months. In all patients, Raynaud's phenomenon was attenuated at around 3 months and had completely disappeared at 6 months. Although transient renal dysfunction was observed in one patient, none of the patients experienced common adverse effects of imatinib, such as edema, nausea, rash, and musculoskeletal pain. These clinical data indicate the tolerability and efficacy of low-dose imatinib in SSc, especially against cutaneous vascular involvement, including Raynaud's phenomenon and nailfold bleeding.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s10165-011-0472-1", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1023369", 
        "issn": [
          "1439-7595", 
          "1439-7609"
        ], 
        "name": "Modern Rheumatology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "22"
      }
    ], 
    "name": "Efficacy of low-dose imatinib mesylate for cutaneous involvement in systemic sclerosis: a preliminary report of three cases", 
    "pagination": "94-99", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "e2c45b600affb3ea119c966e946505fa0da2b5c188dc889b736fd2a91f6eb161"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21633912"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100959226"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10165-011-0472-1"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1047602676"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10165-011-0472-1", 
      "https://app.dimensions.ai/details/publication/pub.1047602676"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T17:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8672_00000515.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs10165-011-0472-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10165-011-0472-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10165-011-0472-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10165-011-0472-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10165-011-0472-1'


 

This table displays all metadata directly associated to this object as RDF triples.

279 TRIPLES      21 PREDICATES      72 URIs      41 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10165-011-0472-1 schema:about N0e8e434d89154704a1963dd0315045ad
2 N196a59c025a54493b7eb698da5bc3f38
3 N24e3e0ee8f42432ea8a46d729f73789d
4 N4369a7a04d9548fa8d384035e5e9daf8
5 N5906efc9f83b4010b24f4bdc1114293e
6 N5bb0440efca14fb19289e9cf9dea02d3
7 N5bc85604ac02404d8f3ae0b21985c548
8 Na2c01d391ec145768b4549613667d925
9 Naf8d739781eb4c1d9a3859c82c941184
10 Nb3af5378913f446ea6b0f92f507eb829
11 Nb7780d22b66d459bab8d30619c6ab2ee
12 Nb95c378936104350a890057d5c4924cd
13 Nbda7e2dba9684b76a5fd3d8bfa26e6b7
14 Nc58bae057442495bad52499bd7d2aa12
15 Ncb3eb0f60c87498b929f29fd8ae2fba7
16 Ncec18cfcde1b449aab67c68cf51f0efa
17 Nd4b1ebd645434612adeba77b95a36d38
18 Ne06f26cee8bf4cafb366d17f3cc00825
19 Ne94478ff676c4c03af28b6826de055df
20 Nf2987da2949e44b1ad1685b158ee5183
21 anzsrc-for:11
22 anzsrc-for:1103
23 schema:author N9717ca46d62f43af8afea809a38f9090
24 schema:citation sg:pub.10.1007/s00392-009-0752-3
25 sg:pub.10.1007/s100670050039
26 sg:pub.10.1038/onc.2008.479
27 sg:pub.10.1186/ar2067
28 https://doi.org/10.1002/1529-0131(199905)42:5<930::aid-anr11>3.0.co;2-1
29 https://doi.org/10.1002/art.20214
30 https://doi.org/10.1002/art.21948
31 https://doi.org/10.1002/art.22314
32 https://doi.org/10.1016/s0002-9440(10)63685-1
33 https://doi.org/10.1074/jbc.m703907200
34 https://doi.org/10.1093/rheumatology/ken104
35 https://doi.org/10.1111/j.1346-8138.2009.00758.x
36 https://doi.org/10.1128/mcb.01278-08
37 https://doi.org/10.1128/mcb.01320-08
38 https://doi.org/10.1136/ard.2010.143974
39 https://doi.org/10.1164/rccm.200702-178oc
40 https://doi.org/10.1182/blood-2009-02-204156
41 https://doi.org/10.1200/jco.2009.25.0779
42 https://doi.org/10.1371/journal.pone.0001452
43 https://doi.org/10.1517/14656566.4.6.963
44 https://doi.org/10.1536/ihj.51.272
45 https://doi.org/10.2353/ajpath.2010.090593
46 https://doi.org/10.4414/smw.2010.13050
47 schema:datePublished 2012-02
48 schema:datePublishedReg 2012-02-01
49 schema:description In this pilot study, the effect of low-dose imatinib mesylate (100 mg/day) on cutaneous involvement in patients with systemic sclerosis (SSc) was analyzed. Three patients with SSc were treated with 100 mg/day of imatinib mesylate for 6 months because of pulmonary arterial hypertension refractory to conventional treatments, including beraprost, bosentan, sildenafil, and epoprostenol. Changes in cutaneous involvement were evaluated at 1, 3, and 6 months. During the treatment, the total skin score gradually improved in all of the patients. Contracture of phalanges was attenuated in two patients, one of whom also experienced the partial restoration of large-joint mobility. Nailfold bleeding, initially seen in two patients, was gradually attenuated and had completely disappeared at 6 months. In all patients, Raynaud's phenomenon was attenuated at around 3 months and had completely disappeared at 6 months. Although transient renal dysfunction was observed in one patient, none of the patients experienced common adverse effects of imatinib, such as edema, nausea, rash, and musculoskeletal pain. These clinical data indicate the tolerability and efficacy of low-dose imatinib in SSc, especially against cutaneous vascular involvement, including Raynaud's phenomenon and nailfold bleeding.
50 schema:genre research_article
51 schema:inLanguage en
52 schema:isAccessibleForFree false
53 schema:isPartOf N00756a1cc2fd4b188e52bafcd14d92d6
54 N95934e0324d347299c03af4bb344720b
55 sg:journal.1023369
56 schema:name Efficacy of low-dose imatinib mesylate for cutaneous involvement in systemic sclerosis: a preliminary report of three cases
57 schema:pagination 94-99
58 schema:productId N297b57db424a4f2c8e46bd18710c7e5c
59 N3f3072d96e23439cb7d6b859cd1b89a5
60 N73e01197308d451da96842ebe4ac114a
61 N8c53f86bf7004756a52c5b72ee131a13
62 Nd3bcb1cfbdc347d8a9b471424af88666
63 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047602676
64 https://doi.org/10.1007/s10165-011-0472-1
65 schema:sdDatePublished 2019-04-10T17:32
66 schema:sdLicense https://scigraph.springernature.com/explorer/license/
67 schema:sdPublisher Ne7bade72a95744609bccb51d95a65047
68 schema:url http://link.springer.com/10.1007%2Fs10165-011-0472-1
69 sgo:license sg:explorer/license/
70 sgo:sdDataset articles
71 rdf:type schema:ScholarlyArticle
72 N00756a1cc2fd4b188e52bafcd14d92d6 schema:volumeNumber 22
73 rdf:type schema:PublicationVolume
74 N0e8e434d89154704a1963dd0315045ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Aged
76 rdf:type schema:DefinedTerm
77 N196a59c025a54493b7eb698da5bc3f38 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Male
79 rdf:type schema:DefinedTerm
80 N24e3e0ee8f42432ea8a46d729f73789d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Imatinib Mesylate
82 rdf:type schema:DefinedTerm
83 N297b57db424a4f2c8e46bd18710c7e5c schema:name pubmed_id
84 schema:value 21633912
85 rdf:type schema:PropertyValue
86 N3f3072d96e23439cb7d6b859cd1b89a5 schema:name dimensions_id
87 schema:value pub.1047602676
88 rdf:type schema:PropertyValue
89 N427277b86ab047e8996e8207675ee040 rdf:first sg:person.016511126157.53
90 rdf:rest Ncdfdf9674f5b4482be5f9810c47db5d4
91 N4369a7a04d9548fa8d384035e5e9daf8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Scleroderma, Systemic
93 rdf:type schema:DefinedTerm
94 N453808033c804ef9a34f14d3d03e66d2 rdf:first sg:person.01272415526.42
95 rdf:rest N6465a8e5573c42449baf283322d11dbc
96 N55fa490b8af440cf87e916fb7122aa09 rdf:first sg:person.01260257610.29
97 rdf:rest Nd173731bda8d41e987e33b78884185f0
98 N5906efc9f83b4010b24f4bdc1114293e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Humans
100 rdf:type schema:DefinedTerm
101 N5bb0440efca14fb19289e9cf9dea02d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Pyrimidines
103 rdf:type schema:DefinedTerm
104 N5bc85604ac02404d8f3ae0b21985c548 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Nails
106 rdf:type schema:DefinedTerm
107 N6465a8e5573c42449baf283322d11dbc rdf:first sg:person.0725464671.87
108 rdf:rest N55fa490b8af440cf87e916fb7122aa09
109 N73e01197308d451da96842ebe4ac114a schema:name readcube_id
110 schema:value e2c45b600affb3ea119c966e946505fa0da2b5c188dc889b736fd2a91f6eb161
111 rdf:type schema:PropertyValue
112 N87f1893551194ff693ca05ec516bda45 rdf:first sg:person.0704171111.13
113 rdf:rest N427277b86ab047e8996e8207675ee040
114 N8c53f86bf7004756a52c5b72ee131a13 schema:name doi
115 schema:value 10.1007/s10165-011-0472-1
116 rdf:type schema:PropertyValue
117 N95934e0324d347299c03af4bb344720b schema:issueNumber 1
118 rdf:type schema:PublicationIssue
119 N9717ca46d62f43af8afea809a38f9090 rdf:first sg:person.01340530726.06
120 rdf:rest N453808033c804ef9a34f14d3d03e66d2
121 Na2c01d391ec145768b4549613667d925 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Nail Diseases
123 rdf:type schema:DefinedTerm
124 Naf8d739781eb4c1d9a3859c82c941184 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Raynaud Disease
126 rdf:type schema:DefinedTerm
127 Nb3af5378913f446ea6b0f92f507eb829 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Piperazines
129 rdf:type schema:DefinedTerm
130 Nb7780d22b66d459bab8d30619c6ab2ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Hemorrhage
132 rdf:type schema:DefinedTerm
133 Nb95c378936104350a890057d5c4924cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Protein Kinase Inhibitors
135 rdf:type schema:DefinedTerm
136 Nbda7e2dba9684b76a5fd3d8bfa26e6b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Range of Motion, Articular
138 rdf:type schema:DefinedTerm
139 Nc58bae057442495bad52499bd7d2aa12 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Skin
141 rdf:type schema:DefinedTerm
142 Ncb3eb0f60c87498b929f29fd8ae2fba7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Middle Aged
144 rdf:type schema:DefinedTerm
145 Ncdfdf9674f5b4482be5f9810c47db5d4 rdf:first sg:person.0772176333.38
146 rdf:rest Ne95140c176044e708b0489f4f5ceabb1
147 Ncec18cfcde1b449aab67c68cf51f0efa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Benzamides
149 rdf:type schema:DefinedTerm
150 Nd173731bda8d41e987e33b78884185f0 rdf:first sg:person.01066532711.30
151 rdf:rest N87f1893551194ff693ca05ec516bda45
152 Nd3bcb1cfbdc347d8a9b471424af88666 schema:name nlm_unique_id
153 schema:value 100959226
154 rdf:type schema:PropertyValue
155 Nd4b1ebd645434612adeba77b95a36d38 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Female
157 rdf:type schema:DefinedTerm
158 Ne06f26cee8bf4cafb366d17f3cc00825 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Contracture
160 rdf:type schema:DefinedTerm
161 Ne7bade72a95744609bccb51d95a65047 schema:name Springer Nature - SN SciGraph project
162 rdf:type schema:Organization
163 Ne94478ff676c4c03af28b6826de055df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Treatment Outcome
165 rdf:type schema:DefinedTerm
166 Ne95140c176044e708b0489f4f5ceabb1 rdf:first sg:person.012237517602.74
167 rdf:rest rdf:nil
168 Nf2987da2949e44b1ad1685b158ee5183 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Dose-Response Relationship, Drug
170 rdf:type schema:DefinedTerm
171 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
172 schema:name Medical and Health Sciences
173 rdf:type schema:DefinedTerm
174 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
175 schema:name Clinical Sciences
176 rdf:type schema:DefinedTerm
177 sg:journal.1023369 schema:issn 1439-7595
178 1439-7609
179 schema:name Modern Rheumatology
180 rdf:type schema:Periodical
181 sg:person.01066532711.30 schema:affiliation https://www.grid.ac/institutes/grid.26999.3d
182 schema:familyName Kawashima
183 schema:givenName Tomohiko
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066532711.30
185 rdf:type schema:Person
186 sg:person.012237517602.74 schema:affiliation https://www.grid.ac/institutes/grid.26999.3d
187 schema:familyName Sato
188 schema:givenName Shinichi
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012237517602.74
190 rdf:type schema:Person
191 sg:person.01260257610.29 schema:affiliation https://www.grid.ac/institutes/grid.26999.3d
192 schema:familyName Yao
193 schema:givenName Atsushi
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260257610.29
195 rdf:type schema:Person
196 sg:person.01272415526.42 schema:affiliation https://www.grid.ac/institutes/grid.26999.3d
197 schema:familyName Asano
198 schema:givenName Yoshihide
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272415526.42
200 rdf:type schema:Person
201 sg:person.01340530726.06 schema:affiliation https://www.grid.ac/institutes/grid.26999.3d
202 schema:familyName Tamaki
203 schema:givenName Zenshiro
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340530726.06
205 rdf:type schema:Person
206 sg:person.016511126157.53 schema:affiliation https://www.grid.ac/institutes/grid.26999.3d
207 schema:familyName Kinugawa
208 schema:givenName Koichiro
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016511126157.53
210 rdf:type schema:Person
211 sg:person.0704171111.13 schema:affiliation https://www.grid.ac/institutes/grid.26999.3d
212 schema:familyName Tomita
213 schema:givenName Manabu
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704171111.13
215 rdf:type schema:Person
216 sg:person.0725464671.87 schema:affiliation https://www.grid.ac/institutes/grid.26999.3d
217 schema:familyName Hatano
218 schema:givenName Masaru
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725464671.87
220 rdf:type schema:Person
221 sg:person.0772176333.38 schema:affiliation https://www.grid.ac/institutes/grid.26999.3d
222 schema:familyName Nagai
223 schema:givenName Ryozo
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772176333.38
225 rdf:type schema:Person
226 sg:pub.10.1007/s00392-009-0752-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015411619
227 https://doi.org/10.1007/s00392-009-0752-3
228 rdf:type schema:CreativeWork
229 sg:pub.10.1007/s100670050039 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024420316
230 https://doi.org/10.1007/s100670050039
231 rdf:type schema:CreativeWork
232 sg:pub.10.1038/onc.2008.479 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033606906
233 https://doi.org/10.1038/onc.2008.479
234 rdf:type schema:CreativeWork
235 sg:pub.10.1186/ar2067 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006941478
236 https://doi.org/10.1186/ar2067
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1002/1529-0131(199905)42:5<930::aid-anr11>3.0.co;2-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006073505
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1002/art.20214 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026529165
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1002/art.21948 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034706037
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1002/art.22314 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017502522
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1016/s0002-9440(10)63685-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047996226
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1074/jbc.m703907200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033962722
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1093/rheumatology/ken104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045972598
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1111/j.1346-8138.2009.00758.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1051092432
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1128/mcb.01278-08 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007691359
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1128/mcb.01320-08 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015563261
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1136/ard.2010.143974 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040415220
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1164/rccm.200702-178oc schema:sameAs https://app.dimensions.ai/details/publication/pub.1037047078
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1182/blood-2009-02-204156 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026415910
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1200/jco.2009.25.0779 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035509430
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1371/journal.pone.0001452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011299071
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1517/14656566.4.6.963 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046161832
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1536/ihj.51.272 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024533354
271 rdf:type schema:CreativeWork
272 https://doi.org/10.2353/ajpath.2010.090593 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001970034
273 rdf:type schema:CreativeWork
274 https://doi.org/10.4414/smw.2010.13050 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072527631
275 rdf:type schema:CreativeWork
276 https://www.grid.ac/institutes/grid.26999.3d schema:alternateName University of Tokyo
277 schema:name Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan
278 Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan
279 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...